DSC Advisors, L.P. - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 62 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
DSC Advisors, L.P. ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$11,205,000
+20.4%
3,365,000
+9.9%
5.37%
+191.6%
Q3 2019$9,310,000
+67.9%
3,062,593
+31.4%
1.84%
+88.8%
Q2 2019$5,546,000
-23.7%
2,330,400
+20.3%
0.98%
-27.0%
Q1 2019$7,266,000
-26.3%
1,937,724
+12.6%
1.34%
+0.9%
Q3 2018$9,863,000
+65.8%
1,721,378
+44.9%
1.32%
+36.7%
Q2 2018$5,950,000
-2.3%
1,187,6040.0%0.97%
-24.1%
Q1 2018$6,092,000
-14.7%
1,187,6040.0%1.28%
-69.2%
Q4 2017$7,138,000
+8.3%
1,187,6040.0%4.14%
+97.2%
Q3 2017$6,591,000
+19.7%
1,187,604
+0.1%
2.10%
+15.8%
Q2 2017$5,506,000
-6.3%
1,186,6540.0%1.82%
-54.7%
Q1 2017$5,874,000
-66.1%
1,186,654
-23.9%
4.00%
-59.2%
Q4 2016$17,316,000
+12.2%
1,560,000
-6.4%
9.82%
+4.6%
Q3 2016$15,440,000
+62.3%
1,667,377
+11.3%
9.38%
+56.7%
Q2 2016$9,514,000
-2.4%
1,498,211
+0.3%
5.99%
+3.4%
Q1 2016$9,743,000
-14.7%
1,494,399
+6.1%
5.79%
-3.0%
Q4 2015$11,424,000
+55.9%
1,408,597
+40.9%
5.97%
+67.7%
Q3 2015$7,330,000
-27.4%
1,000,000
+1.6%
3.56%
-32.2%
Q2 2015$10,094,000
+25.2%
984,734
+13.0%
5.25%
+22.7%
Q1 2015$8,063,000
+114.3%
871,653
+62.4%
4.28%
+292.3%
Q4 2014$3,762,000
+219.6%
536,620
+148.6%
1.09%
+84.3%
Q3 2014$1,177,000215,8960.59%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q3 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$28,738,0004.90%
DSC Advisors, L.P. 1,187,604$7,138,0004.14%
Opaleye Management Inc. 960,000$5,769,0001.85%
DAFNA Capital Management LLC 352,741$2,120,0001.14%
Vivo Capital, LLC 855,000$5,139,0001.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 382,838$2,301,0000.81%
SENZAR ASSET MANAGEMENT, LLC 377,397$2,268,0000.58%
Sio Capital Management, LLC 131,200$789,0000.44%
Perceptive Advisors 1,117,324$6,715,0000.22%
Tekla Capital Management LLC 930,398$5,592,0000.22%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders